{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:06:07Z","timestamp":1793419567699,"version":"4.5.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1093\/toxsci\/kfr088","type":"journal-article","created":{"date-parts":[[2011,4,20]],"date-time":"2011-04-20T20:39:42Z","timestamp":1303331982000},"page":"1-6","source":"Crossref","is-referenced-by-count":531,"title":["Thalidomide: The Tragedy of Birth Defects and the Effective Treatment of Disease"],"prefix":"10.1093","volume":"122","author":[{"given":"James H.","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony R.","family":"Scialli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,4,19]]},"reference":[{"key":"key\n\t\t\t\t20170315194042_bib1","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1073\/pnas.91.9.4082","article-title":"Thalidomide is an inhibitor of angiogenesis","volume":"91","year":"1994","journal-title":"Proc. Nat. Acad Sci. U. S. A."},{"key":"key\n\t\t\t\t20170315194042_bib2","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0002-9343(99)00408-8","article-title":"Thalidomide: current and potential clinical applications","volume":"108","year":"2000","journal-title":"Am. J. Med."},{"key":"key\n\t\t\t\t20170315194042_bib3","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/(SICI)1096-9926(199612)54:6<273::AID-TERA1>3.0.CO;2-#","article-title":"Thalidomide, a current teratogen in South America","volume":"54","year":"1996","journal-title":"Teratology."},{"key":"key\n\t\t\t\t20170315194042_bib4","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/bdrb.20115","article-title":"Evaluation of the developmental toxicity of lenalidomide in rabbits","volume":"80","year":"2007","journal-title":"Birth Defects Res. B Dev. Repro. Tox."},{"key":"key\n\t\t\t\t20170315194042_bib5","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1124\/mol.64.2.415","article-title":"Thalidomide down-regulates transcript levels of GC-rich promoter genes in multiple myeloma","volume":"64","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"key\n\t\t\t\t20170315194042_bib6","first-page":"3","article-title":"History and scope of toxicology","volume-title":"Casarett and Doull\u2019s Toxicology: The Basic Science of Poisons","year":"2008","edition":"(7th ed.)"},{"key":"key\n\t\t\t\t20170315194042_bib7","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0890-6238(99)00053-2","article-title":"Differential alteration by thalidomide of the glutathione content of rat vs. rabbit conceptuses in vitro","volume":"13","year":"1999","journal-title":"Reprod. Toxicol."},{"key":"key\n\t\t\t\t20170315194042_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/152308604771978291","article-title":"A novel hypothesis for thalidomide-induced limb teratogenesis: redox misregulation of the NF-kappaB pathway","volume":"6","year":"2004","journal-title":"Antiox. Redox. Sig."},{"key":"key\n\t\t\t\t20170315194042_bib9","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/dvdy.10150","article-title":"Misregulation of gene expression in the redox-sensitive NF-kappab-dependent limb outgrowth pathway by thalidomide","volume":"225","year":"2002","journal-title":"Dev. Dyn."},{"key":"key\n\t\t\t\t20170315194042_bib10","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1126\/science.1177319","article-title":"Identification of a primary target of thalidomide teratogenicity","volume":"327","year":"2010","journal-title":"Science."},{"key":"key\n\t\t\t\t20170315194042_bib11","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.yrtph.2007.11.007","article-title":"A retrospective analysis of developmental toxicity studies in rat and rabbit: what is the added value of the rabbit as an additional test species?","volume":"50","year":"2008","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"key\n\t\t\t\t20170315194042_bib12","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1200\/JCO.2010.28.0792","article-title":"Genetic factors underlying the risk of thalidomide-related neuropathy in patients with multiple myeloma","volume":"29","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"key\n\t\t\t\t20170315194042_bib13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/tera.1420380305","article-title":"Thalidomide update: regulatory aspects","volume":"38","year":"1988","journal-title":"Teratology."},{"key":"key\n\t\t\t\t20170315194042_bib14","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.4161\/cc.7.9.5793","article-title":"Shedding light on an old mystery: thalidomide suppresses survival pathways to induce limb defects","volume":"7","year":"2008","journal-title":"Cell Cycle."},{"key":"key\n\t\t\t\t20170315194042_bib15","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1128\/MCB.00553-07","article-title":"Thalidomide induces limb anomalies by PTEN stabilization, Akt suppression, and stimulation of caspase-dependent cell death","volume":"28","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"key\n\t\t\t\t20170315194042_bib16","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1096\/fj.06-7603com","article-title":"Thalidomide induces limb deformities by perturbing the Bmp\/Dkk1\/Wnt signaling pathway","volume":"21","year":"2007","journal-title":"FASEB. J."},{"key":"key\n\t\t\t\t20170315194042_bib17","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1515\/znc-1986-11-1218","article-title":"Evidence for the intercalation of thalidomide into DNA: clue to the molecular mechanism of thalidomide teratogenicity?","volume":"41","year":"1986","journal-title":"Zeitschrift fur Naturforschung."},{"key":"key\n\t\t\t\t20170315194042_bib18","first-page":"2554","article-title":"[How can the physician prevent dangers for the offspring?]","volume":"48","year":"1962","journal-title":"Die Medizinische Welt."},{"key":"key\n\t\t\t\t20170315194042_bib19","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/tera.1420380303","article-title":"A short history of thalidomide embryopathy","volume":"38","year":"1988","journal-title":"Teratology"},{"key":"key\n\t\t\t\t20170315194042_bib21","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0149-2918(03)80085-1","article-title":"Thalidomide: a review of approved and investigational uses","volume":"25","year":"2003","journal-title":"Clin. Therap."},{"key":"key\n\t\t\t\t20170315194042_bib22","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/(SICI)1096-9926(199911)60:5<306::AID-TERA11>3.0.CO;2-Y","article-title":"Teratogen update: thalidomide: a review, with a focus on ocular findings and new potential uses","volume":"60","year":"1999","journal-title":"Teratology."},{"key":"key\n\t\t\t\t20170315194042_bib23","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/bdra.20609","article-title":"Thalidomide and misoprostol: ophthalmologic manifestations and associations both expected and unexpected","volume":"85","year":"2009","journal-title":"Birth Defects Res. A Clin. Mol. Teratol."},{"key":"key\n\t\t\t\t20170315194042_bib24","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/BF00338341","article-title":"[The sensitive phase in thalidomide embryopathy]","volume":"1","year":"1965","journal-title":"Humangenetik."},{"key":"key\n\t\t\t\t20170315194042_bib25","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/8466","article-title":"Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity","volume":"5","year":"1999","journal-title":"Nat. Med."},{"key":"key\n\t\t\t\t20170315194042_bib26","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/1096-9926(200009)62:3<172::AID-TERA4>3.0.CO;2-T","article-title":"Teratology Society Public Affairs Committee position paper: thalidomide","volume":"62","author":"Public Affairs Committee (PAC)","year":"2000","journal-title":"Teratology."},{"key":"key\n\t\t\t\t20170315194042_bib27","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/bdra.20384","article-title":"New cases of thalidomide embryopathy in Brazil","volume":"79","year":"2007","journal-title":"Birth Defects Res. A Clin. Mol. Teratol."},{"key":"key\n\t\t\t\t20170315194042_bib28","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/cpt196563303","article-title":"Thalidomide in the treatment of lepra reactions","volume":"6","year":"1965","journal-title":"Clin. Pharmacol. Therap."},{"key":"key\n\t\t\t\t20170315194042_bib29","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1365-4362.1980.tb00342.x","article-title":"The treatment of lepra reaction in lepromatous leprosy. Fifteen years\u2019 experience with thalidomide","volume":"19","year":"1980","journal-title":"Int. J. Dermat."},{"key":"key\n\t\t\t\t20170315194042_bib30","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/tera.1420380307","article-title":"Proposed mechanisms of action in thalidomide embryopathy","volume":"38","year":"1988","journal-title":"Teratology."},{"key":"key\n\t\t\t\t20170315194042_bib31","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/S0006-2952(99)00388-3","article-title":"Mechanism of action in thalidomide teratogenesis","volume":"59","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"key\n\t\t\t\t20170315194042_bib32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/(SICI)1096-9926(200003)61:3<189::AID-TERA6>3.0.CO;2-W","article-title":"Hypothesis: thalidomide embryopathy-proposed mechanism of action","volume":"61","year":"2000","journal-title":"Teratology."},{"key":"key\n\t\t\t\t20170315194042_bib33","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1073\/pnas.0901505106","article-title":"Thalidomide induces limb defects by preventing angiogenic outgrowth during early limb formation","volume":"106","year":"2009","journal-title":"Proc. Nat. Acad. Sci. U. S. A."},{"key":"key\n\t\t\t\t20170315194042_bib34","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2165\/00002018-200629040-00003","article-title":"Thalidomide use in the US: experience with pregnancy testing in the S.T.E.P.S. programme","volume":"29","year":"2006","journal-title":"Drug Saf."},{"key":"key\n\t\t\t\t20170315194042_bib35","volume-title":"Guidelines for Reproduction Studies for Safety Evaluation of Drugs for Human Use","author":"U.S. FDA","year":"1966"},{"key":"key\n\t\t\t\t20170315194042_bib36","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/tera.1420380304","article-title":"Why I doubted that thalidomide was the cause of the epidemic of limb defects of 1959 to 1961","volume":"38","year":"1988","journal-title":"Teratology."},{"key":"key\n\t\t\t\t20170315194042_bib37","doi-asserted-by":"crossref","first-page":"S354","DOI":"10.1016\/j.taap.2005.01.061","article-title":"Molecular and biochemical mechanisms in teratogenesis involving reactive oxygen species","volume":"207","year":"2005","journal-title":"Toxicol. Appl. Pharmacol."}],"container-title":["Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/toxsci\/article-pdf\/122\/1\/1\/10999918\/kfr088.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T01:39:24Z","timestamp":1560130764000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/toxsci\/article\/1672454\/Thalidomide:"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,19]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2011,4,19]]},"published-print":{"date-parts":[[2011,7]]}},"URL":"https:\/\/doi.org\/10.1093\/toxsci\/kfr088","relation":{},"ISSN":["1096-6080","1096-0929"],"issn-type":[{"value":"1096-6080","type":"print"},{"value":"1096-0929","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,19]]}}}